X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ: XFOR · Real-Time Price · USD
0.2280
+0.0063 (2.84%)
At close: Apr 2, 2025, 4:00 PM
0.2299
+0.0019 (0.83%)
After-hours: Apr 2, 2025, 7:51 PM EDT
X4 Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Cash & Equivalents | 55.7 | 99.22 | 121.72 | 81.79 | 78.71 | Upgrade
|
| Short-Term Investments | 46.36 | 15 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 102.06 | 114.22 | 121.72 | 81.79 | 78.71 | Upgrade
|
| Cash Growth | -10.64% | -6.16% | 48.82% | 3.91% | -37.62% | Upgrade
|
| Accounts Receivable | 1.07 | - | - | - | - | Upgrade
|
| Other Receivables | 0.64 | 0.56 | 1.15 | 0.75 | 0.92 | Upgrade
|
| Receivables | 1.71 | 0.56 | 1.15 | 0.75 | 0.92 | Upgrade
|
| Inventory | 2.82 | - | - | - | - | Upgrade
|
| Prepaid Expenses | 5.59 | 7.05 | 5.52 | 5.34 | 3.42 | Upgrade
|
| Restricted Cash | - | 0.25 | 0.29 | - | 0.26 | Upgrade
|
| Total Current Assets | 112.18 | 122.08 | 128.68 | 87.88 | 83.31 | Upgrade
|
| Property, Plant & Equipment | 4.84 | 6.4 | 8.33 | 10.22 | 9.2 | Upgrade
|
| Goodwill | 17.35 | 17.35 | 17.35 | 17.35 | 27.11 | Upgrade
|
| Other Intangible Assets | 10 | - | - | - | - | Upgrade
|
| Other Long-Term Assets | 2.08 | 1.44 | 1.23 | 1.72 | 3.26 | Upgrade
|
| Total Assets | 146.45 | 147.26 | 155.59 | 117.18 | 122.87 | Upgrade
|
| Accounts Payable | 8.62 | 8.95 | 7.78 | 4.28 | 3.14 | Upgrade
|
| Accrued Expenses | 23.01 | 12.82 | 11.44 | 7.85 | 8.02 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 1.32 | 0.8 | - | Upgrade
|
| Current Portion of Leases | 1.25 | 1.1 | 1.2 | 1.08 | 0.79 | Upgrade
|
| Other Current Liabilities | - | - | 0.59 | 0.03 | - | Upgrade
|
| Total Current Liabilities | 32.88 | 22.86 | 22.32 | 14.02 | 11.95 | Upgrade
|
| Long-Term Debt | 75.43 | 54.57 | 32.3 | 33.14 | 33.18 | Upgrade
|
| Long-Term Leases | 1.41 | 2.61 | 3.6 | 4.78 | 4.48 | Upgrade
|
| Other Long-Term Liabilities | 14.59 | 16.12 | 23.3 | 0.83 | 0.46 | Upgrade
|
| Total Liabilities | 124.3 | 96.16 | 81.54 | 52.76 | 50.07 | Upgrade
|
| Common Stock | 0.17 | 0.17 | 0.12 | 0.03 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 537.46 | 528.96 | 450.79 | 347.37 | 267.08 | Upgrade
|
| Retained Earnings | -515.36 | -477.91 | -376.74 | -282.87 | -194.18 | Upgrade
|
| Comprehensive Income & Other | -0.12 | -0.12 | -0.12 | -0.12 | -0.12 | Upgrade
|
| Total Common Equity | 22.15 | 51.1 | 74.05 | 64.41 | 72.8 | Upgrade
|
| Shareholders' Equity | 22.15 | 51.1 | 74.05 | 64.41 | 72.8 | Upgrade
|
| Total Liabilities & Equity | 146.45 | 147.26 | 155.59 | 117.18 | 122.87 | Upgrade
|
| Total Debt | 78.09 | 58.28 | 38.42 | 39.79 | 38.45 | Upgrade
|
| Net Cash (Debt) | 23.97 | 55.94 | 83.3 | 42 | 40.26 | Upgrade
|
| Net Cash Growth | -57.14% | -32.85% | 98.32% | 4.33% | -61.02% | Upgrade
|
| Net Cash Per Share | 0.12 | 0.31 | 1.31 | 1.63 | 2.01 | Upgrade
|
| Filing Date Shares Outstanding | 173.66 | 167.94 | 122.21 | 30.81 | 17.38 | Upgrade
|
| Total Common Shares Outstanding | 170.95 | 167.43 | 121.67 | 28.13 | 16.31 | Upgrade
|
| Working Capital | 79.3 | 99.21 | 106.35 | 73.86 | 71.36 | Upgrade
|
| Book Value Per Share | 0.13 | 0.31 | 0.61 | 2.29 | 4.46 | Upgrade
|
| Tangible Book Value | -5.2 | 33.75 | 56.7 | 47.06 | 45.69 | Upgrade
|
| Tangible Book Value Per Share | -0.03 | 0.20 | 0.47 | 1.67 | 2.80 | Upgrade
|
| Machinery | 2.43 | 2.11 | 2.08 | 1.98 | 1.25 | Upgrade
|
| Leasehold Improvements | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade
|
Updated Mar 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.